Resources from the same session
The Importance of Patient Empowerment During Their Journey
Presenter: Terri Conneran
Session: Bristol Myers Squibb - Evolving Patient-Centered Therapies for Metastatic NSCLC
Resources:
Webcast
PD-L1 <1% in Metastatic NSCLC: Guiding Treatment Decisions for Potential Durable Outcomes in a Patient Population With Unmet Needs
Presenter: Luis Paz-Ares
Session: Bristol Myers Squibb - Evolving Patient-Centered Therapies for Metastatic NSCLC
Resources:
Webcast
Kicking Off Targeted Medicine for Patients With KRAS G12C–Mutated Metastatic NSCLC
Presenter: Jarushka Naidoo
Session: Bristol Myers Squibb - Evolving Patient-Centered Therapies for Metastatic NSCLC
Resources:
Webcast
Next-Generation Tyrosine Kinase Inhibitors: The Evolving Treatment Landscape of Cancers With ROS1 or NTRK Fusions
Presenter: Alexander Drilon
Session: Bristol Myers Squibb - Evolving Patient-Centered Therapies for Metastatic NSCLC
Resources:
Webcast
Panel Discussion: What Would Be Your Treatment Decision?
Presenter: Jarushka Naidoo, Luis Paz-Ares, Terri Conneran, Alexander Drilon
Session: Bristol Myers Squibb - Evolving Patient-Centered Therapies for Metastatic NSCLC
Resources:
Webcast
Closing Remarks
Presenter: Jarushka Naidoo
Session: Bristol Myers Squibb - Evolving Patient-Centered Therapies for Metastatic NSCLC
Resources:
Webcast